Page 44 - Read Online
P. 44

Page 10 of 10                             Polykandriotis et al. Plast Aesthet Res 2018;5:37  I  http://dx.doi.org/10.20517/2347-9264.2018.52

                   Pharmacol Res 2006;53:89-103.
               48.  Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood
                   2000;96:3772-8.
               49.  Smith JD, Melhem ME, Magge KT, Waggoner AS, Campbell PG. Improved growth factor directed vascularization into fibrin constructs
                   through inclusion of additional extracellular molecules. Microvasc Res 2007;73:84-94.
               50.  Beier JP, Boos AM, Kamolz L, Vogt PM, Koller R, Horch RE. Skin tissue engineering--from split skin to engineered skin grafts? Handchir
                   Mikrochir Plast Chir 2010;42:342-53.
               51.  Horch RE, Bannasch H, Kopp J, Andree C, Stark GB. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute
                   the epidermis. Cell Transplant 1998;7:309-17.
               52.  Liang X, Yang D, Hu J, Hao X, Gao J, Mao Z. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth
                   factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma. Anticancer Res 2008;28:1659-66.
               53.  Zeng M, Shen J, Liu Y, Lu LY, Ding K, Fortmann SD, Khan M, Wang J, Hackett SF, Semenza GL, Campochiaro PA. The HIF-1 antagonist
                   acriflavine: visualization in retina and suppression of ocular neovascularization. J Mol Med (Berl) 2017;95:417-29.
               54.  Peet DJ, Kittipassorn T, Wood JP, Chidlow G, Casson RJ. HIF signalling: the eyes have it. Exp Cell Res 2017;356:136-40.
               55.  André H, Tunik S, Aronsson M, Kvanta A. Hypoxia-inducible factor-1α is associated with sprouting angiogenesis in the murine laser-
                   induced choroidal neovascularization model. Invest Ophthalmol Vis Sci 2015;56:6591-604.
               56.  Robering JW, Weigand A, Pfuhlmann R, Horch RE, Beier JP, Boos AM. Mesenchymal stem cells promote lymphangiogenic properties of
                   lymphatic endothelial cells. J Cell Mol Med 2018; doi: 10.1111/jcmm.13590.
               57.  An R, Schmid R, Klausing A, Robering JW,  Weber M, Bäuerle  T, Detsch R, Boccaccini AR, Horch RE, Boos AM,  Weigand A.
                   Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model. FASEB J
                   2018; doi: 10.1096/fj.201800135RR.
               58.  Hutmacher DW, Horch RE, Loessner D, Rizzi S, Sieh S, Reichert JC, Clements JA, Beier JP, Arkudas A, Bleiziffer O, Kneser U.
                   Translating tissue engineering technology platforms into cancer research. J Cell Mol Med 2009;13:1417-27.
               59.  Qin F, Dardik H, Pangilinan A, Robinson J, Chuy J, Wengerter K. Remodeling and suppression of intimal hyperplasia of vascular grafts
                   with a distal arteriovenous fistula in a rat model. J Vasc Surg 2001;34:701-6.
               60.  Westerband A, Crouse D, Richter LC, Aguirre ML, Wixon CC, James DC, Mills JL, Hunter GC, Heimark RL. Vein adaptation to
                   arterialization in an experimental model. J Vasc Surg 2001;33:561-9.
               61.  Butany  J,  Mahendran  R,  Nair  V,  Lindsay  T.  Postimplantation  changes  in  a  composite  pericardium-vein  graft.  Cardiovasc  Pathol
                   2004;13:237-9.
   39   40   41   42   43   44   45   46   47   48   49